AI Science Tracker
EN

Integrative Analysis of 5-Hydroxymethylcytosine and Transcriptional Profiling Identified 5hmC-Modified lncRNA Panel as Non-Invasive Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer.

The First Affiliated Hospital of Wenzhou Medical University · 25 Mar 2022 · medicine

Discovery

Integrative Analysis of 5-Hydroxymethylcytosine and Transcriptional Profiling Identified 5hmC-Modified lncRNA Panel as Non-Invasive Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer.

Source check: Source checked. Not independent scientific confirmation.

Finding: 5-hydroxymethylcytosine profile predicts disease status with a reported clinical cohort evaluation. Organization is unavailable in the deposited bibliographic metadata.

Technology: 5hmC-modified lncRNA diagnostic and prognostic models

Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning and Cox-regression models used plasma cfDNA 5hmC-modified lncRNAs to classify pancreatic adenocarcinoma and stratify prognosis.
Test and result
5-hydroxymethylcytosine profile predicts disease status with a reported clinical cohort evaluation.
Limitation / still unknown
The reviewed study does not establish validation or benefit beyond its reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8990848/

The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.